Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial

• Published in: PloS one Vol. 18; no. 6; p. e0286307
• Main Authors: Malmborg, Morten, Assad Turky Al-Kahwa, Ali, Kober, Lars, Torp-Pedersen, Christian, Butt, Jawad H, Zahir, Deewa, Tuxen, Christian D, Poulsen, Mikael K, Madelaire, Christian, Fosbol, Emil, Gislason, Gunnar, Hildebrandt, Per, Andersson, Charlotte, Gustafsson, Finn, Schou, Morten
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 08.06.2023; Public Library of Science (PLoS)
• Subjects: Adrenergic beta-Antagonists - therapeutic use; Aged; Angiotensin; Angiotensin Receptor Antagonists; Angiotensin-converting enzyme inhibitors; Care and treatment; Case reports; Clinics; Confidence intervals; Congestive heart failure; Death; Diagnosis; Drug dosages; Ejection fraction; Emigration; Enzyme inhibitors; Female; Follow-Up Studies; Health aspects; Health care; Health risks; Heart failure; Heart Failure - drug therapy; Hospitalization; Humans; Immigration; Male; Medical research; Medicine and Health Sciences; Medicine, Experimental; Mortality; Optimization; Patients; People and Places; Peptidyl-dipeptidase A; Pharmaceutical industry; Primary care; Primary Health Care; Registries; Stroke Volume; Denmark

Whether continued follow-up in specialized heart failure (HF) clinics after optimization of guideline-directed therapy improves long-term outcomes in patients with HF with reduced ejection fraction (HFrEF) is unknown. 921 medically optimized HFrEF patients enrolled in the NorthStar study were random...